You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

MEDUNIK Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for MEDUNIK, and what generic and branded alternatives to MEDUNIK drugs are available?

MEDUNIK has two approved drugs.



Summary for MEDUNIK
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for MEDUNIK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medunik NITISINONE nitisinone CAPSULE;ORAL 212390-003 May 26, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up
Medunik PHEBURANE sodium phenylbutyrate PELLETS;ORAL 216513-001 Jun 17, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up
Medunik NITISINONE nitisinone CAPSULE;ORAL 212390-002 May 26, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up
Medunik NITISINONE nitisinone CAPSULE;ORAL 212390-004 Apr 27, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up
Medunik NITISINONE nitisinone CAPSULE;ORAL 212390-001 May 26, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.